Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease
Open Access
- 1 December 2015
- journal article
- research article
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 40 (6) , 630-637
Abstract
Background/Aims: The use of antihypertensive medicines has been shown to reduce proteinuria, morbidity, and mortality in patients with chronic kidney disease (CKD). A specific recommendation for a class of antihypertensive drugs is not available in this population, despite the pharmacodynamic differences. We have therefore analysed the association between antihypertensive medicines and survival of patients with chronic kidney disease. Methods: Out of 2687 consecutive patients undergoing kidney biopsy a cohort of 606 subjects with retrievable medical therapy was included into the analysis. Kidney function was assessed by glomerular filtration rate (GFR) estimation at the time point of kidney biopsy. Main outcome variable was death. Results: Overall 114 (18.7%) patients died. In univariate regression analysis the use of alpha-blockers and calcium channel antagonists, progression of disease, diabetes mellitus (DM) type 1 and 2, arterial hypertension, coronary heart disease, peripheral vascular disease, male sex and age were associated with mortality (all pConclusion: The use of calcium channel blockers but not of other antihypertensive medicines is associated with mortality in primarily GN patients with CKD.Keywords
This publication has 32 references indexed in Scilit:
- Renin-Angiotensin Inhibition in Systolic Heart Failure and Chronic Kidney DiseaseThe American Journal of Medicine, 2012
- Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patientsKidney International, 2011
- Targeting the Renin Angiotensin System in Dialysis PatientsSeminars in Dialysis, 2011
- Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patientsNephrology Dialysis Transplantation, 2008
- Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal diseaseKidney International, 2007
- Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive PatientsHypertension, 2005
- Cardiovascular Therapies and Risk for Development of DiabetesJACC, 2004
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Association of calcium channel blockers and mortality in haemodialysis patientsClinical Science, 2002